Anti‐ischemic effects of inotropic agents in experimental right ventricular infarction

Background: Right ventricular (RV) function is an important determinant of survival after myocardial infarction. The efficacy of reperfusion therapy might be increased by the cardioprotective action of inotropic agents, which are used for symptomatic therapy in situations with compromised hemodynamics. Therefore, we used a porcine model of RV ischemia and reperfusion (IR) injury to study the influence of milrinone, levosimendan and dobutamine on the extent and degree of myocardial injury.

[1]  R. Rossaint,et al.  Establishment of a porcine right ventricular infarction model for cardioprotective actions of xenon and isoflurane , 2008, Acta anaesthesiologica Scandinavica.

[2]  A. Domínguez-Rodríguez,et al.  Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty. , 2008, International journal of cardiology.

[3]  M. Miyazaki,et al.  6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (Cilostazol), a Phosphodiesterase Type 3 Inhibitor, Reduces Infarct Size via Activation of Mitochondrial Ca2+-Activated K+ Channels in Rabbit Hearts , 2008, Journal of Pharmacology and Experimental Therapeutics.

[4]  J. Spear,et al.  beta1-Adrenoreceptor activation contributes to ischemia-reperfusion damage as well as playing a role in ischemic preconditioning. , 2007, American journal of physiology. Heart and circulatory physiology.

[5]  L. Algotsson,et al.  Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model , 2007, Acta anaesthesiologica Scandinavica.

[6]  M. Maeng,et al.  Effects of Levosimendan on Myocardial Infarct Size and Hemodynamics in a Closed-Chest Porcine Ischemia–Reperfusion Model , 2006, Cardiovascular Drugs and Therapy.

[7]  H. Sakamoto,et al.  Effects of olprinone on myocardial ischemia-reperfusion injury in dogs. , 2006, The Journal of veterinary medical science.

[8]  E. Berenshtein,et al.  Flumazenil Mimics whereas Midazolam Abolishes Ischemic Preconditioning in a Rabbit Heart Model of Ischemia–Reperfusion , 2006, Anesthesiology.

[9]  J. Vinten-johansen,et al.  Postconditioning: reduction of reperfusion-induced injury. , 2006, Cardiovascular research.

[10]  K. Ropella,et al.  Ischemia-reperfusion injury changes the dynamics of Ca2+-contraction coupling due to inotropic drugs in isolated hearts. , 2006, Journal of applied physiology.

[11]  I. Paraskevaidis,et al.  Anti-inflammatory and anti-apoptotic effects of levosimendan in decompensated heart failure: a novel mechanism of drug-induced improvement in contractile performance of the failing heart. , 2005, Current medicinal chemistry. Cardiovascular and hematological agents.

[12]  J. Goldstein.  Pathophysiology and management of right heart ischemia. , 2002, Journal of the American College of Cardiology.

[13]  M. Hori,et al.  Cardioprotective Effect Afforded by Transient Exposure to Phosphodiesterase III Inhibitors: The Role of Protein Kinase A and p38 Mitogen-Activated Protein Kinase , 2001, Circulation.

[14]  W. Schlack,et al.  Ketamine, but Not S (+)-ketamine, Blocks Ischemic Preconditioning in Rabbit Hearts In Vivo , 2001, Anesthesiology.

[15]  E. Pehkonen,et al.  Beneficial effects of ischemic preconditioning on right ventricular function after coronary artery bypass grafting. , 2000, The Annals of thoracic surgery.

[16]  H. Majewski,et al.  Amrinone reduces ischaemia-reperfusion injury in rat heart. , 2000, European journal of pharmacology.

[17]  P. Pagel,et al.  Levosimendan, a New Positive Inotropic Drug, Decreases Myocardial Infarct Size via Activation of KATP Channels , 2000, Anesthesia and analgesia.

[18]  J. Vinten-johansen,et al.  The role of neutrophils in myocardial ischemia-reperfusion injury. , 1999, Cardiovascular research.

[19]  L. Opie,et al.  Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart. , 1999, The Journal of pharmacology and experimental therapeutics.

[20]  L. Agati.  Microvascular integrity after reperfusion therapy. , 1999, American heart journal.

[21]  W. O’Neill,et al.  Effect of reperfusion on biventricular function and survival after right ventricular infarction. , 1998, The New England journal of medicine.

[22]  Division on Earth.  Guide for the Care and Use of Laboratory Animals , 1996 .

[23]  W. Herzog,et al.  Timing of magnesium therapy affects experimental infarct size. , 1995, Circulation.

[24]  A. Branzi,et al.  Limitation of Myocardial Infarct Size by Nicorandil After Sustained Ischemia in Pigs , 1995, Journal of cardiovascular pharmacology.

[25]  B. Lucchesi,et al.  Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury. , 1995, Cardiovascular research.

[26]  W. Klaus,et al.  A quantitative comparison of functional and anti‐ischaemic effects of the phosphodiesterase‐inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts , 1994, British journal of pharmacology.

[27]  J. Moran,et al.  Long-term amiodarone administration protects against global myocardial ischemia. , 1990, The Annals of thoracic surgery.

[28]  L. Becker,et al.  Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. , 1989, Circulation.

[29]  K. Mullane,et al.  Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. , 1985, Journal of pharmacological methods.

[30]  M. Fishbein,et al.  Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. , 1981, American heart journal.

[31]  R. Fryer,et al.  Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs. , 2008, American journal of physiology. Heart and circulatory physiology.

[32]  T. Miura,et al.  Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy , 2008, Basic Research in Cardiology.

[33]  M. Zioga,et al.  Dopamine mimics the cardioprotective effect of ischemic preconditioning via activation of alpha1-adrenoceptors in the isolated rat heart. , 2006, Physiological research.

[34]  M. Entman,et al.  The inflammatory response in myocardial infarction. , 2002, Cardiovascular research.